Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway

Osteosarcoma is the most common type of malignant bone cancer and results in cancer-related deaths among adolescents. Alantolactone (ALT) demonstrates antitumor properties in various diseases; however, its potential role in osteosarcoma is relatively unclear. The aim of the present study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Weng, Qiuyan, Han, Jinming, Chen, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947914/
https://www.ncbi.nlm.nih.gov/pubmed/31974628
http://dx.doi.org/10.3892/mmr.2019.10882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947914/
https://www.ncbi.nlm.nih.gov/pubmed/31974628
http://dx.doi.org/10.3892/mmr.2019.10882

Ejemplares similares